Joshua T. Kantrowitz

High dose D-serine in the treatment of schizophrenia

Joshua T. Kantrowitz, Anil K. Malhotra, Barbara A. Cornblatt et al. · Schizophrenia Research · 2010 · 242 citations · Full text

Psychiatry, Psychotic Disorder, Medicine +9

D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial

Joshua T. Kantrowitz, Scott W. Woods, Eva Petkova et al. · The Lancet Psychiatry · 2015 · 148 citations

Psychiatry, Psychotic Disorder, Schizophrenia +6

Neural mechanisms of mismatch negativity dysfunction in schizophrenia

Migyung Lee, Pejman Sehatpour, Matthew J. Hoptman et al. · Molecular Psychiatry · 2017 · 126 citations · Full text

Mismatch Negativity Dysfunction, Neuropsychology, Psychiatry +10

Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms

Joshua T. Kantrowitz, Michael L. Epstein, Migyung Lee et al. · Schizophrenia Research · 2017 · 125 citations

Neuropsychology, Psychiatry, Psychotic Disorder +11

Auditory Emotion Recognition Impairments in Schizophrenia: Relationship to Acoustic Features and Cognition

Rinat Gold, Pamela D. Butler, Nadine Revheim et al. · American Journal of Psychiatry · 2012 · 122 citations